Glycyrrhizin preparations for transmucosal absorption
US6890547B1 · kind B1 · utility
15Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2000 |
| Grant date | May 10, 2005 |
| Priority date | — |
| Expiry date | Aug 17, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
By blending glycyrrhizin with an ester mixture comprising a C6-18 fatty acid glycerol ester with a C6-18 fatty acid macrogol ester, glycyrrhizin can be efficiently absorbed via mucosae, in particular, digestive mucosae to achieve a therapeutically effective plasma glycyrrhizin concentration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.